Quantum dots: A new tool for anti-malarial drug assays

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Ku, Min Je ^a   Dossin, Fernando M ^a   Choi, Youngseon ^b   Moraes, Carolina B ^a   Ryu, Jiyoung ^b   Song, Rita ^b   Freitas Junior, Lucio H ^a  

^a Institute Pasteur Korea   (South Korea)

^b Institut Pasteur Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; LACTATE DEHYDROGENASE; QUANTUM DOT; ANTIMALARIAL AGENT;

ANIMAL CELL; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG SCREENING; ERYTHROCYTE; FLOW CYTOMETRY; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; IMMUNOFLUORESCENCE TEST; NONHUMAN; PARASITE DEVELOPMENT; PARASITEMIA; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; SENSITIVITY AND SPECIFICITY; ANIMAL; DRUG SENSITIVITY; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; PARASITOLOGY; TIME;

ANIMALS; ANTIMALARIALS; ERYTHROCYTES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; QUANTUM DOTS; TIME FACTORS;

EID: 79955685714     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-118     Document Type: Article

References (18)

1. WHO, World Malaria Report 2010 2010
2. Artemisinin resistance on the Thai-Cambodian border. O Muller A Sie P Meissner RH Schirmer B Kouyate, Lancet 2009 374 1419 19854368
3. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. H Noedl Y Se S Sriwichai K Schaecher P Teja-Isavadharm B Smith W Rutvisuttinunt D Bethell S Surasri MM Fukuda D Socheat L Chan Thap, Clin Infect Dis 2010 51 82 89 10.1086/657120 21028985
4. Quantum dot bioconjugates for imaging, labelling and sensing. IL Medintz HT Uyeda ER Goldman H Mattoussi, Nature Materials 2005 4 435 446 10.1038/nmat1390 15928695 (Pubitemid 40774047)
5. Quantum dots as strain- and metabolism-specific microbiological labels. JA Kloepfer RE Mielke MS Wong KH Nealson G Stucky JL Nadeau, Appl Environ Microbiol 2003 69 4205 4213 10.1128/AEM.69.7.4205-4213.2003 12839801 (Pubitemid 36870084)
6. Core-shell CdS/Cd(OH)(2) quantum dots: synthesis and bioconjugation to target red cells antigens. PMA De Farias BS Santos FD De Menezes RD Ferreira MD Barjas-Castro V Castro PRM Lima A Fontes CL Cesar, J Microsc 2005 219 103 108 10.1111/j.1365-2818.2005.01501.x 16176249 (Pubitemid 41413514)
7. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. AM Derfus WCW Chan SN Bhatia, Advanced Materials 2004 16 961 966 10.1002/adma.200306111
8. In situ visualization of gene expression using polymer-coated quantum-dot-DNA conjugates. Y Choi HP Kim SM Hong JY Ryu SJ Han R Song, Small 2009 5 2085 2091 10.1002/smll.200900116 19517489
9. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Y Xing Q Chaudry C Shen KY Kong HE Zhau L WChung JA Petros RM O'Regan MV Yezhelyev JW Simons MD Wang S Nie, Nature Protoc 2007 2 1152 1165 10.1038/nprot.2007.107 (Pubitemid 46901294)
10. positively charged compact quantum dot-DNA complexes for detection of nucleic acids. J Lee Y Choi J Kim E Park R Song, Chemphyschem 2009 10 806 811 10.1002/cphc.200800504 19253931
11. Band 3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots. F Tokumasu RM Fairhurst GR Ostera NJ Brittain J Hwang TE Wellems JA Dvorak, J Cell Sci 2005 118 1091 1098 10.1242/jcs.01662 15731014 (Pubitemid 40484897)
12. PEG-ylated cationic CdSe/ZnS QDs as an efficient intracellular labeling agent. J Lee J Kim E Park S Jo R Song, Physical Chemistry Chemical Physics 2008 10 1739 1742 18350178
13. In vivo cancer targeting and imaging with semiconductor quantum dots. XH Gao YY Cui RM Levenson LWK Chung SM Nie, Nature Biotech 2004 22 969 976 10.1038/nbt994 (Pubitemid 39014473)
14. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. XY Wu HJ Liu JQ Liu KN Haley JA Treadway JP Larson NF Ge F Peale MP Bruchez, Nature Biotech 2003 21 41 46 10.1038/nbt764 (Pubitemid 36055825)
15. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. MT Makler JM Ries JA Williams JE Bancroft RC Piper BL Gibbins DJ Hinrichs, Am J Trop Med Hyg 1993 48 739 741 8333566 (Pubitemid 23238452)
16. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. TS Skinner LS Manning WA Johnston TM Davis, Int J Parasitol 1996 26 519 525 10.1016/0020-7519(96)89380-5 8818732 (Pubitemid 26244548)
17. Quantum dots for live cells, in vivo imaging, and diagnostics. X Michalet FF Pinaud LA Bentolila JM Tsay S Doose JJ Li G Sundaresan AM Wu SS Gambhir S Weiss, Science 2005 307 538 544 10.1126/science.1104274 15681376 (Pubitemid 40165671)
18. Quantum dot bioconjugates for imaging, labelling and sensing. IL Medintz HT Uyeda ER Goldman H Mattoussi, Nat Mater 2005 4 435 446 10.1038/nmat1390 15928695 (Pubitemid 40774047)